Viralytics Ltd (OTCQX International:VRACY)

0.95
Delayed Data
As of Mar 23
 0.00 / 0.00%
Today’s Change
0.70
Today|||52-Week Range
2.25
+28.38%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$58.3M

Company Description

Viralytics Ltd. is a biotechnology company. The company focuses on the development of oncolytic immunotherapies that harness the power of certain viruses to infect and kill cancer cells. Its products include CAVATAK™ and EVATAK™. The company was founded on August 14, 1986 and is headquartered in Sydney, Australia.

Contact Information

Viralytics Ltd.
66 Hunter Street
Sydney New South Wales (nsw) 2000
P:(129) 988-4000
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Malcolm L. McCollChief Executive Officer, Director & MD
Robert C. VickeryChief Financial Officer
Darren ShafrenChief Scientific Officer
Sarah PrinceSecretary

To view my watchlist

Not a member yet?

Sign up now for a free account